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Abstract In addition to preventing tissue energy loss during cardiopulmonary bypass, pentoxifylline (Ptx) prevents
the production of pro-inflammatory cytokines as well.The aim of this study was to investigate whether Ptx decreases
the inflammatory effects of cardiopulmonary bypass on the lungs during open-heart surgery.The patients in the study
group (n=15) who were going through an open-heart surgery had 500mgl1 of Ptx added to their prime solution,
whereas the patients in the controlgroup (n=10) onlyreceivedprime solution.Pre-pump andpost-pumpblood samples
were obtained from both groups and assayed for interleukin-6 (IL-6), interleukin-8 (IL-8) and tumour necrosis factor
alpha (TNFa).Lung tissue samples thatwere obtained after the pumpwere examinedwith lightmicroscopy and stained
for tissueTNFa.Non-parametricWilcoxontestwasutilized for statistical evaluation.Inthepost-pumpperiod, the differ-
ence in the IL-6, IL-8 and TNFa levels of the two groups was found to be statistically significant (Po0?005).The tissue
samples from the control group had significant staining withTNFa..We think that Ptx has important protective effects
onthe lungs duringcardiopulmonarybypass.r2002 Elsevier Science Ltd
doi:10.1053/rmed.2001.1255, available online at http://www.idealibrary.comon
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During cardiopulmonary bypass the lungs are exposed
to several types of insults such as ischaemia^reper-
fusion injury, in£ammatory responses and re-expansion
injury (1). These factors interact in an attempt to
increase each other’s damaging capacity, and tissue injury
occurs as a result of a complexmetabolic chain of events.
Pentoxifylline (Ptx) avoids dephosphorylazation of ade-
nosine monophospate (AMP) to adenosine and
inosine monoposphate (IMP) to inosine via inhibition
of 50 -nucleotidase (50 -NT) and exterminate these pre-
cursors from cell during cardiopulmonary bypass.*Ptx
also inhibits the production of pro-in£ammatory cyto-
kines and have anti-in£ammatory properties. Ptx de-
creases tissue injury by exerting its e¡ect at di¡erentReceived 27 March 2001, accepted in revised form14 November 2001.
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3365505; E-mail: hustunsoy@yahoo.comsteps of this metabolic chain (2).Our aimwas to investi-
gate these e¡ects of Ptx on lungs during cardiopulmon-
ary bypass.
MATERIALSANDMETHOD
The study was conducted on the patients who had
gone through open-heart surgery in our department
between December 1999^May 2000 with the autho-
rity of the Board of Ethics of the Gaziantep University
Medical Faculty Hospital issued as of 9 June 1999
and after their written consents were obtained.
According to demographic data, the patients
were blindly divided into two subgroups. Both
groups had approximately the same average age,
diagnosis and female ^male ratio. The surgeon, the
biochemist and the pathologist were blind to the
grouping
The average age of the patients in the study group
(n=15) was 36?5yrs, the female to male ratio was 2/1
and their diagnoses were valvular heart disease (n=13),
TABLE 1. Measurements of cytokines in the both groups*
Before CPB** After CPB**
IL^6 (pgml 1)
Controlgroup 8?3472?08 7187116?78
Studygroup 10?873?01 205748?81
IL^8 (pgml1)
Controlgroup 60?0717?02 8317148?68
Studygroup 48?6714?92 43?7713?11
TNFa (pgml1)
Controlgroup 8?872?02 104?6729?82
Studygroup 10?572?92 10?872?51
*Values aremean7SEM.
** CPB = Cardiopulmonarybypass.
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fect (n=1).Control group patients (n=10) had an average
age of 34?4 yrs, female tomale ratio of 3/2 and their diag-
noses were valvular heart disease (n=7), ASD (n=1) and
VSD (n=2).
All the patients received intravenous anesthesia with
fentanyl (10mgkg1), Midazolam (0?05mgkg1) and Ve-
curonium (0?1mgkg1 induction, 0?05mgkg1 mainte-
nance).
The average duration of pumping was125min for the
study group and 110min for the control group. The
average duration of cross-clamp was calculated as
85 min for the study group and 80min for the control
group. Standard prime solutions that consisted of
ringer lactate, NaHCO3 (1mgkg
1), corticosteroid
(1mgkg1), mannitol (20mgkg1) and antibiotics
were used in the control group. Five hundred mgl1Ptx
was added to the prime solution for the study group
(2,3).
According to the preliminary study results, pre-
pump and post-pump left atrium blood samples were
collected from both groups and interleukin-6 (IL-6),
interleukin-8 (IL-8) and tumour necrosis factor alpha
(TNFa) levelswere determinedwith chemiluminescence
enzyme immunometric assays on an Immulite immu-
noassay analyser (Immulite IL-6, IL-8, TNFa assays,
DPC, Los Angeles,CA,USA). In these assays the chemi-
luminescent substrate, a phosphate ester of adamantyl
dioxetane, undergoes hydrolysis in the presence of alka-
line phosphatase resulting in the sustained emission of
light.
The analytical sensitivity of the IL-6, IL-8 and TNFa
assays were 1pgml1, 2 pgml1 and 1.7 pgml1 and the
lower reportable ranges were 5pgml1, 5 pgml1
and 4pgml1 respectively.Control sera ILCO10009 and
ILC0 20009 were included in each analytic run. Intra-
assay and interassay precision performances of the as-
says that were determined on 10 replicates in a single
run and 20 di¡erent runs, respectively, yielded coe⁄-
cients of variation within 3?4^8?8% at 13?3 and
31?4pgml1 concentrations for IL-6, at 117?0
and 584?0pgml1 concentrations for IL-8 and at
65.0 and 281?0pgml1 concentrations for TNFa. The
lung tissue samples that were obtained after the pump
were stained for tissueTNFawith immunohystochemical
streptavidin^biotin method. Five-micron tissue
sections were placed on the adhesive slides (poly-
L-lysine, Sigma no P 8920) andmicrowaved with antigen
retrieval solution for 10min.The monoclonal antibodies
toTNFa (NeomarkersMS1073,USA)wasused for immu-
nohistochemical staining of the sections. Streptavidin^
biotin, horseradish peroxidasemethod (DAKO, LSAB 2,
K 0675) and DAB chromogenewas used for immunohis-
tochemical staining. The sections were washed with
phosphate-bu¡ered saline (PBS) to prevent drying. Final-
ly Mayer’s haematoxylinwas used as counterstain.To control the lung tissues stained, we used the tonsil
tissuemacrophages thatwererecommendedon the data
sheet of Neomarkers MS 1073, and also transsuced the
antigen retrieval solutions at the same time as the lung
preparations.
We observed light and dark brown areas in the sto-
plasmic tonsil tissue macrophages and the lung tissue at
the light microscopic examination.The brown area con-
tained tissueTNFa and the nuclei were stained blue and
violet.
For the statistical comparison of the data that were
obtained from both groups, the non-parametricWilcox-
on test was utilized.
RESULTS
In the left atrium blood samples that were obtained
before the pump, mean IL-6, IL-8 and TNFa values
did not show any signi¢cant di¡erence between the
two groups (P40?05) (Table 1, Fig. 1). In the left
atrium blood samples that were obtained after the
pump, mean IL-6, IL-8 and TNFa values showed signi¢-
cant di¡erences between the two groups (Po0?005)
(Table1, Fig.1).
In the control group, the tissue samples had signi¢-
cant staining for TNFa, whereas there was only mild
accumulation of tissueTNFa in the study group (Figs 2
and 3).
DISCUSSION
During a cardiopulmonary bypass operation, the
metabolites that are produced as result of in£ammation
and ischaemia^reperfusion injury damage the lung
tissue. With the activation of 50nucleotidase enzyme
in the tissue’s ischaemia phase, ATP is converted to
AMP and IMP, adenosine, inosine and hypoxanthine.
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FIG. 1. IL-6 blood levels of left atrium; (b): IL-8 blood levels of
Left atrium; (c): Blood TNFa levels of Left atrium. CPB=cardio-
pulmonarybypass; control, ; study, .
TRANSMISSIONOFLAYEREDVIDEOSTREAMOVERTHE INTERNET 277Meanwhile, Ca2+ accumulates within the cell due the
altered ion balance. During the reperfusion period,
the reaction of hypoxanthine with the accumulated
Ca2+ results in the formation of reactive oxygen
metabolites within the cell (4). Reperfusion of the
ischaemic tissue increases the concentrations of
chemotactic factors such as lipid mediators, poly-
peptidemediators and immune complexes (5,6). Chemo-
tactic factors attract monocytes, polymorpho-
nuclear leukocytes (PNL) and macrophages to the
environment.
The lung is one of the largest reservoirs for
monocytes, macrophages and PNLs. During cardio-
pulmonary bypass, in addition to ischaemia^reperfusion
injury, an in£ammatory reaction occurs as a result
of PNL accumulation in the lungs.The PNLs thatmigrate
to the tissue as a result of the in£ammatory process
initiates the tissue damage by triggering several reac-
tions (7).
PNLs that accumulate in the tissue secrete myeloper-
oxidase,whichproduceshydroxychloride (HOCl).HOCl
has a direct cytotoxic e¡ect and, by inactivating a1-pro-tease inhibitor, it participates in the production of col-
lagenases and elastases from the PNLs (8^10).
The PNLs that are in the environment, favour the se-
cretion of pro-in£amatory cytokines such as IL-6, IL-8
and TNFa (11).
Ptx has been reported to inhibit the production of
pro-in£ammatory cytokines and to have anti-in£amma-
tory properties. It protects themitochondria structures
of the cell at the same time (12).
Animal and human myocardial studies have demon-
strated that newbornmyocardium had higher resistance
to ischaemia.This ¢nding is supported by the low levels
of 50nucleotidase activity in themyocardium of the new-
borns (13).
Ptx exerts its e¡ect by inhibiting the activity
of 50nucleotidase enzyme. It prevents the evolution
of future metabolic chains that have potential hazards
while preserving the energy stores which will be
required at the time of reperfusion. This shows us that
Ptxcouldbeusedduring cardiopulmonarybypass to pro-
tect themyocardium (2,11,13^15).
The reaction that occurs during cardiopulmonary by-
pass is not limited to the myocardium, but can a¡ect
other organs of the body as well. As a result of this, per-
ipheral organ systems including the lungs can be harmed
to varying degrees (1,13,16).
In order to evaluate the protective e¡ect of Ptx the
present study determined the IL-6, IL-8 and TNFa levels
inblood samples obtained from the left atrium andTNFa
stainwas performed at the tissue level.
In an in vivo studyperformedbyYoshikietal. (14) in par-
allel to the in£ammation thatoccurredduring the ischae-
mia, the levels of IL-6, IL-8 andblood TNFa increased as a
result of the activation of PNLs and monocytes and
macrophages were reported. In the same study, with
the administration of Ptx, IL-6, IL-8 and blood TNFa le-
vels decreased when compared to those of the control
group. The results of Cain et al. also supported these
¢ndings (15).
In thepresent study, if the levels of IL-6, IL-8 and TNFa
are analyzed, there is a statistically signi¢cant di¡erence
between the two groups. In the light of this observation,
we think that the tissue in£ammatory response and
ischaemia^reperfusion damage has been reduced to a
great extent in the control group patients.
In the study byTˇrk˛z et al., it was reported that Ptx,
by inhibiting the PNL activation in the lungs, prevented
the accumulation of the cells, thereby reducing the da-
mage to the lungs (17). Kleinschmidt et al. stated that
Ptx could decrease endothelial damage and permeability
(1).
TNFa, which is a pro-in£ammatory cytokine, can ac-
cumulate in the tissue aswell as beingreleased to the cir-
culation.The tissue staining forTNFa wasminimal in the
study group, whereas the control group showed a great
degree of staining.
FIG. 2. Increased levels of TNFa, meant that expanded brown areas were visualized in the alveolar wall of control group samples
(Immunohistochemistry,X200).
FIG. 3. In the alveolar wall of studygroup samples, smallbrown areaswere visualized (Immunohistochemistry,X200).
278 RESPIRATORYMEDICINEAccording to the evidence collected from the bio-
chemical and microscopic data, the tissue in£ammatory
response and ischaemia-reperfusion injury was signi¢-
cantly diminished in the study group.In conclusion, in the light of the results we have ob-
tained, we think that Ptx can play an important role in
the prevention of lung damage that can occur during car-
diopulmonary bypass.
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